325 related articles for article (PubMed ID: 12435836)
1. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.
Estrada AL
Public Health Rep; 2002; 117 Suppl 1(Suppl 1):S126-34. PubMed ID: 12435836
[TBL] [Abstract][Full Text] [Related]
2. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
3. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts.
Baozhang T; Kaining Z; Jinxing K; Ruchang X; Ming L; Caixia Z; Li T
Epidemiol Infect; 1997 Dec; 119(3):343-7. PubMed ID: 9440438
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
5. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
[TBL] [Abstract][Full Text] [Related]
6. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
7. Health disparities among African-American and Hispanic drug injectors--HIV, AIDS, hepatitis B virus and hepatitis C virus: a review.
Estrada AL
AIDS; 2005 Oct; 19 Suppl 3():S47-52. PubMed ID: 16251828
[TBL] [Abstract][Full Text] [Related]
8. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
[TBL] [Abstract][Full Text] [Related]
9. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
10. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
11. The role of needle exchange programs in HIV prevention.
Vlahov D; Junge B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of viral infections among intravenous drug users in northern California.
Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N
West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
[TBL] [Abstract][Full Text] [Related]
14. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
Koester S; Glanz J; Barón A
AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
[TBL] [Abstract][Full Text] [Related]
15. Assessment of risky injection practices associated with hepatitis B, hepatitis C, and human immunodeficiency virus and using the blood-borne virus transmission risk assessment questionnaire.
Reynolds GL; Fisher DG; Napper LE
J Addict Dis; 2012; 31(1):80-8. PubMed ID: 22356671
[TBL] [Abstract][Full Text] [Related]
16. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
Kim NJ; Jin H; McFarland W; Raymond HF
Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
[TBL] [Abstract][Full Text] [Related]
17. Risk contexts and risk behaviors in the Euregion Maas-Rhein: the Boule de Neige intervention for AIDS prevention among drug users.
Franken IH; Kaplan CD
AIDS Educ Prev; 1997 Apr; 9(2):161-80. PubMed ID: 9167801
[TBL] [Abstract][Full Text] [Related]
18. Syringe exchange and risk of infection with hepatitis B and C viruses.
Hagan H; McGough JP; Thiede H; Weiss NS; Hopkins S; Alexander ER
Am J Epidemiol; 1999 Feb; 149(3):203-13. PubMed ID: 9927214
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty.
Rhodes T; Davis M; Judd A
Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
